Pratteln, Switzerland

Peter Rebmann

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Cerenis Therapeutics Holding S.a.. Active years: 2017.

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Peter Rebmann: A Pioneer in Sphingomyelin Synthesis

Introduction

Peter Rebmann, an accomplished inventor based in Prattein, Switzerland, has made significant contributions to the field of biochemistry through his innovative work. With a total of two patents to his name, he has focused primarily on the synthesis of sphingolipids, which are critical components in cellular function and signaling.

Latest Patents

Rebmann's latest patents present groundbreaking methods for the synthesis of sphingomyelins and dihydrosphingomyelins. These patents also extend to the synthesis of sphingosines, dihydrosphingosines, ceramides, and dihydroceramides. The meticulous procedures outlined in his inventions aim to enhance the efficiency and efficacy of producing these vital biomolecules, which have implications in various therapeutic applications.

Career Highlights

Peter Rebmann has been instrumental in advancing the biochemical research landscape. His tenure at Cerenis Therapeutics Holding S.A. has allowed him to work on innovative projects that bridge research and practical applications. His dedication to scientific exploration and his expertise in synthesis methodologies underscore his role as a key figure in his field.

Collaborations

Throughout his career, Rebmann has collaborated with notable colleagues, including Daniela Carmen Oniciu and Stefan Heckhoff. These partnerships have fostered a collaborative environment that encourages the sharing of ideas and strengthens the research initiatives at Cerenis Therapeutics. Joint research efforts have the potential to drive further innovations and enhance the understanding of lipid biology.

Conclusion

In conclusion, Peter Rebmann stands out as an influential inventor whose work in the synthesis of sphingomyelins and related compounds contributes to the advancement of biochemistry. His innovative patents and collaborative spirit exemplify the importance of continuous research and development in the pursuit of scientific knowledge and therapeutic advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…